FDA inspection
InBody Co., Ltd.: FDA inspection ending Aug 10, 2017
FDA inspection 1026454 · No Action Indicated (NAI) · Cheonan
Key facts
| Inspection ID | 1026454 |
|---|---|
| Firm | InBody Co., Ltd. |
| FEI number | 3003074886 |
| Address | (Ju)Baioseupeiseu, 15 Heugam-Gil; Seobuk |
| City | Cheonan |
| Country | Korea (the Republic of) |
| Fiscal year | 2017 |
| Inspection end date | Aug 10, 2017 |
| Classification | No Action Indicated (NAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data